Cardinal Health Inc. (CAH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Cardinal Health Inc. (CAH) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (66/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+119.5% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How CAH Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $222.58B | 3.7% | 1% | $1.56B | $1.85B | 22.7% |
| FY 2024 | $226.83B | 3.3% | 0.5% | $852.0M | $3.25B | 23.4% |
| FY 2023 | $204.98B | 44% | 0.4% | $330.0M | -$6.38B | 0.4% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring CAH)
- ✓Live walkthrough of CAH's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
CAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -1.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CAH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CAH. Explore sector supply chains on /butterfly.
CAH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Cardinal Health Inc. (CAH)?
In FY 2025 (10-K), CAH converted $222.6B of revenue into a 3.7% gross margin, 1% operating margin, and $1.9B in free cash flow (0.8% FCF margin).